European Journal of Cancer
Publication date:
2000-01-01
Volume:
36
Pages:
S1 -
S9
Publisher:
Pergamon
Author:
Vergote, Ignace
Neven, Patrick ; Van Dam, P ; Serreyn, R ; De Prins, F ; De Sutter, P ; Albertyn, G ; Vergote, Ignace ; Neven, P
Keywords:
Science & Technology, Life Sciences & Biomedicine, Oncology, TAMOXIFENS THERAPEUTIC BENEFIT, SURGICAL ADJUVANT BREAST, ENDOMETRIAL CANCER, POSTMENOPAUSAL PATIENTS, AROMATASE INHIBITORS, RANDOMIZED-TRIAL, PREVENTION, RALOXIFENE, EXPRESSION, ER, Aromatase Inhibitors, Belgium, Breast Neoplasms, Female, Genital Neoplasms, Female, Humans, Menopause, Receptors, Estrogen, Selective Estrogen Receptor Modulators, Tamoxifen, 1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services, Oncology & Carcinogenesis, 3211 Oncology and carcinogenesis